Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis

被引：0
|
作者：
J. Iwamoto
K. Makita
Y. Sato
T. Takeda
H. Matsumoto
机构：
[1] Keio University School of Medicine,Institute for Integrated Sports Medicine
[2] Keiyu Orthopaedic Hospital,Department of Orthopaedic Surgery
[3] Keio University School of Medicine,Department of Obstetrics and Gynecology
[4] Mitate Hospital,Department of Neurology
来源：
Osteoporosis International | 2011年 / 22卷
关键词：
Alendronate; Back pain; Elcatonin; Osteoporosis; Postmenopausal women;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2735 / 2742
页数：7
相关论文
共 50 条
  • [1] Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis
    Iwamoto, J.
    Makita, K.
    Sato, Y.
    Takeda, T.
    Matsumoto, H.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (10) : 2735 - 2742
  • [2] Elcatonin in Combination with Risedronate Is More Effective than Risedronate Alone for Relieving Back Pain in Postmenopausal Women with Osteoporosis
    Takakuwa, Masayuki
    Iwamoto, Jun
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (07) : 1159 - 1165
  • [3] Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial
    Michio Hongo
    Naohisa Miyakoshi
    Yuji Kasukawa
    Yoshinori Ishikawa
    Yoichi Shimada
    Journal of Bone and Mineral Metabolism, 2015, 33 : 432 - 439
  • [4] Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial
    Hongo, Michio
    Miyakoshi, Naohisa
    Kasukawa, Yuji
    Ishikawa, Yoshinori
    Shimada, Yoichi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2015, 33 (04) : 432 - 439
  • [5] Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
    Sanad, Z.
    Ellakwa, H.
    Desouky, B.
    CLIMACTERIC, 2011, 14 (03) : 369 - 377
  • [6] Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
    Ljunggren, Osten
    Barrett, Annabel
    Stoykov, Ivaylo
    Langdahl, Bente L.
    Lems, Willem F.
    Walsh, J. Bernard
    Fahrleitner-Pammer, Astrid
    Rajzbaum, Gerald
    Jakob, Franz
    Karras, Dimitrios
    Marin, Fernando
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [7] Alendronate improves QOL of postmenopausal women with osteoporosis
    Kawate, Hisaya
    Ohnaka, Keizo
    Adachi, Masahiro
    Kono, Suminori
    Ikematsu, Hideyuki
    Matsuo, Hisashi
    Higuchi, Kazumi
    Takayama, Takehiko
    Takayanagi, Ryoichi
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 123 - 131
  • [8] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
  • [9] Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis
    Sewerynek, Ewa
    Dabrowska, Katarzyna
    Skowronska-Jozwiak, Elibieta
    Zygmunt, Arkadiusz
    Lewinski, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2009, 60 (02) : 76 - 81
  • [10] Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis
    Iwamoto, Jun
    Sato, Yoshihiro
    Uzawa, Mitsuyoshi
    Takeda, Tsuyoshi
    Matsumoto, Hideo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 201 - 206
12345